Shares of Walgreen Boots Alliance and Rite Aid are trading lower after the merger of the two drugstore companies is facing US antitrust concerns. » Read More
By: Rachel Cao
The Apple chip provider reported first quarter earnings of $1.61 per share on revenues of $914 million. » Read More
By: Bob Pisani
Trump offered precious little about the issues that would matter most to earnings: tax cuts and infrastructure spending. » Read More
Oil's rally giving boost to stocks.
Travel companies saw their stocks fall as the industry grappled with the attacks in Brussels.
The terror in Belgium may also dampen consumer sentiment, which has been key to Europe's economic recovery, market watchers tell CNBC.
Using Kensho, a tool designed to quantify historical market events, we searched for what happens to markets after deadly terror attacks in Europe.
David Stockman says the Federal Reserve's actions could devastate the market. Here's why.
"This market is on solid footing and ready for the next leg up," technical analyst Craig Johnson says.
Using data from Kensho, a tool designed to quantify historical market events, CNBC Pro analyzed the impact of stock buyback seasonality on market returns.
The Brussels attacks are unlikely to have a long-term impact on markets, but could create roadblocks to commerce and give Euro sceptics momentum.
Sherwin-Williams crafted an escape route in its deal to buy Valspar, Breakingviews reports.
Some of the names on the move ahead of the open.
As the United States and Cuba start to normalize relations, traders picked stocks that could benefit from business on the island.
Jim Cramer has his eye on one pharma stock that could come out ahead of the rest at the end of the election year.
Jim Cramer was surprised at the premium Sherwin-Williams paid for Valspar and outlined the implications to the rest of the industry.
A small shareholder is lobbying Citigroup and JPMorgan to break up — and his ideas may be gaining traction on Wall Street.
Oil experts joined CNBC to discuss the crude volatility, prices and a potential catalyst not priced in the market, yet.
We need to move sideways before we have a shot at another leg up. Otherwise, you quickly get into oversold territory.
Get the best of CNBC in your inbox